Survival rates improving for many Americans with a variety of cancers
the ONA take:
According to a new report published in the journal JAMA Oncology, researchers from the Cancer Epidemiology Research Program at the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee, have found that survival rates are improving for many people with breast, colon, liver, lung, and prostate cancer.
Survival rates are particularly improving for those diagnosed at younger ages. The researchers also observed differences in survival based on race.
Specifically, blacks had poorer survival compared with whites. Of note, results showed black women with ovarian cancer experienced an increase in risk of death over the last 20 years.
In addition, many patients aged 50 to 64 with breast, colorectal, liver, or prostate cancer had significantly increased odds of survival, but patients aged 75 to 85 with the same cancers had smaller decreases in risk of death.
For the study, researchers analyzed data on over 1 million patients diagnosed with breast, colorectal, liver, lung, ovarian, pancreatic, or prostate cancer between 1990 and 2009 from the U.S. National Cancer Institute Surveillance, Epidemiology and End Results (SEER) study.

A cancer false alarm may give false sense of security
Sign Up for Free e-newsletters
ONA Articles
- FDA: Number of U.S. Women With Breast Implant-Caused Cancer Has Increased
- Sequential Immunotherapy, Targeted Therapy Linked to Cutaneous Adverse Events in Advanced Melanoma
- Takeda to Collaborate With MSKCC on CAR-T Therapies for Multiple Myeloma
- Immunotherapy for HER2-positive Breast Cancer: Recent Advances and Combination Therapeutic Approaches
- NIH Establishes Educational Program on Genomics, Genetics for Oncology Nurses
- Oncology Nurse Navigation Facilitates Timely Treatment of Pancreatic Cancer
- Oncology Nurses Weigh In on Their Patient-Centered Communication Practices, Needs
- Substitute for Lidocaine
- CART cell therapy for prostate cancer: status and promise
- Shifting Dynamics of Social Support After a Cancer Diagnosis
- Nurse-Led vs Oncologist-Led Breast Cancer Follow-up Program: Early Feasibility Results of an Ongoing Study
- Immunotherapy for HER2-positive Breast Cancer: Recent Advances and Combination Therapeutic Approaches
- Survey Demonstrates Relationship Between Symptom Burden, Medical Disability Leave Among Myeloproliferative Neoplasms
- A Review of Clinical Outcomes in Patients With Early-Stage Burkitt Lymphoma
- FDA: Number of U.S. Women With Breast Implant-Caused Cancer Has Increased
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
Bone Cancer | Regimens | Drugs |
Brain Cancer | Regimens | Drugs |
Breast Cancer | Regimens | Drugs |
Endocrine Cancer | Regimens | Drugs |
Gastrointestinal Cancer | Regimens | Drugs |
Genitourinary Cancer | Regimens | Drugs |
Gynecologic Cancer | Regimens | Drugs |
Head and Neck Cancer | Regimens | Drugs |
Hematologic Cancer | Regimens | Drugs |
Lung Cancer | Regimens | Drugs |
Other Cancers | Regimens | |
Rare Cancers | Regimens | |
Skin Cancer | Regimens | Drugs |